Jiangsu Yangnong Chemical (600486) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
13 Jun, 2025Executive summary
Revenue for the first nine months of 2024 was RMB 8.02 billion, down 13.57% year-over-year.
Net profit attributable to shareholders was RMB 1.03 billion, a decrease of 24.61% compared to the same period last year.
Basic and diluted EPS were both RMB 2.524, down 25.06% year-over-year.
Financial highlights
Operating cash flow for the first nine months was RMB 3.10 billion, down 14.39% year-over-year.
Total assets at quarter-end were RMB 17.11 billion, up 8.96% from the end of last year.
Shareholders' equity reached RMB 10.38 billion, a 7.27% increase from year-end 2023.
Non-recurring gains for the period totaled RMB 39.08 million, mainly from government subsidies and asset disposals.
Key financial ratios and metrics
Gross margin for the first nine months was 24.01%, compared to 26.17% in the prior year period.
Weighted average return on equity was 11.68%, down 4.84 percentage points year-over-year.
Latest events from Jiangsu Yangnong Chemical
- Revenue and profit declined sharply, but cost controls and R&D remained robust.600486
H2 202422 Dec 2025 - H1 2025 revenue and profit rose despite global challenges; interim dividend declared.600486
H1 202522 Dec 2025 - Revenue up 14.23% and net profit up 2.88% year-over-year, but cash flow declined 31.50%.600486
Q3 202528 Oct 2025 - Net profit fell 32% on lower prices, but cash flow and net assets increased.600486
H1 202413 Jun 2025 - Q1 2025 saw modest revenue and profit growth, but operating cash flow declined.600486
Q1 20256 Jun 2025